AKBA logo

Akebia Therapeutics (AKBA) Gross profit

Annual gross profit:

$97.00M-$23.47M(-19.48%)
December 31, 2024

Summary

  • As of today (June 28, 2025), AKBA annual gross profit is $97.00 million, with the most recent change of -$23.47 million (-19.48%) on December 31, 2024.
  • During the last 3 years, AKBA annual gross profit has risen by +$36.02 million (+59.08%).
  • AKBA annual gross profit is now -53.12% below its all-time high of $206.92 million, reached on December 31, 2022.

Performance

AKBA Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

quarterly gross profit:

$49.71M+$23.58M(+90.23%)
March 31, 2025

Summary

  • As of today (June 28, 2025), AKBA quarterly gross profit is $49.71 million, with the most recent change of +$23.58 million (+90.23%) on March 31, 2025.
  • Over the past year, AKBA quarterly gross profit has increased by +$28.71 million (+136.70%).
  • AKBA quarterly gross profit is now -53.87% below its all-time high of $107.77 million, reached on June 30, 2022.

Performance

AKBA quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

TTM gross profit:

$125.71M+$28.71M(+29.60%)
March 31, 2025

Summary

  • As of today (June 28, 2025), AKBA TTM gross profit is $125.71 million, with the most recent change of +$28.71 million (+29.60%) on March 31, 2025.
  • Over the past year, AKBA TTM gross profit has increased by +$4.05 million (+3.33%).
  • AKBA TTM gross profit is now -40.23% below its all-time high of $210.34 million, reached on September 30, 2019.

Performance

AKBA TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

AKBA Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-19.5%+136.7%+3.3%
3 y3 years+59.1%+63.8%+70.7%
5 y5 years-48.9%-18.2%-39.9%

AKBA Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-53.1%+59.1%-53.9%+376.5%-39.5%+70.7%
5 y5-year-53.1%+5392.0%-53.9%+158.8%-39.9%+380.0%
alltimeall time-53.1%+5392.0%-53.9%+158.8%-40.2%+380.0%

AKBA Gross profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$49.71M(+90.2%)
$125.71M(+29.6%)
Dec 2024
$97.00M(-19.5%)
$26.13M(+12.3%)
$97.00M(-10.5%)
Sep 2024
-
$23.27M(-12.5%)
$108.40M(-0.7%)
Jun 2024
-
$26.60M(+26.7%)
$109.17M(-10.3%)
Mar 2024
-
$21.00M(-44.0%)
$121.66M(+1.0%)
Dec 2023
$120.47M(-41.8%)
$37.53M(+56.1%)
$120.48M(-15.3%)
Sep 2023
-
$24.04M(-38.5%)
$142.16M(+10.6%)
Jun 2023
-
$39.09M(+97.3%)
$128.55M(-34.8%)
Mar 2023
-
$19.82M(-66.5%)
$197.22M(-5.1%)
Dec 2022
$206.92M(+239.3%)
$59.21M(+467.5%)
$207.76M(+31.0%)
Sep 2022
-
$10.43M(-90.3%)
$158.60M(-12.4%)
Jun 2022
-
$107.77M(+255.0%)
$180.98M(+145.8%)
Mar 2022
-
$30.36M(+202.0%)
$73.64M(+20.8%)
Dec 2021
$60.98M
$10.05M(-69.4%)
$60.98M(+41.3%)
Sep 2021
-
$32.81M(+7749.8%)
$43.16M(+7.9%)
DateAnnualQuarterlyTTM
Jun 2021
-
$418.00K(-97.6%)
$39.99M(-189.1%)
Mar 2021
-
$17.70M(-327.9%)
-$44.90M(+2349.5%)
Dec 2020
-$1.83M(-101.0%)
-$7.77M(-126.2%)
-$1.83M(-104.9%)
Sep 2020
-
$29.64M(-135.1%)
$37.34M(-39.2%)
Jun 2020
-
-$84.47M(-239.0%)
$61.41M(-70.6%)
Mar 2020
-
$60.77M(+93.5%)
$209.02M(+10.2%)
Dec 2019
$189.66M(-5.2%)
$31.41M(-41.5%)
$189.66M(-9.8%)
Sep 2019
-
$53.71M(-14.9%)
$210.34M(+0.3%)
Jun 2019
-
$63.13M(+52.5%)
$209.79M(+7.3%)
Mar 2019
-
$41.41M(-20.5%)
$195.45M(-2.3%)
Dec 2018
$199.97M(+10.3%)
$52.08M(-2.0%)
$199.97M(+35.2%)
Sep 2018
-
$53.17M(+9.0%)
$147.89M(+56.1%)
Jun 2018
-
$48.79M(+6.2%)
$94.72M(+106.2%)
Mar 2018
-
$45.93M
$45.93M
Dec 2017
$181.23M(>+9900.0%)
-
-
Dec 2016
$1.53M
-
-

FAQ

  • What is Akebia Therapeutics annual gross profit?
  • What is the all time high annual gross profit for Akebia Therapeutics?
  • What is Akebia Therapeutics annual gross profit year-on-year change?
  • What is Akebia Therapeutics quarterly gross profit?
  • What is the all time high quarterly gross profit for Akebia Therapeutics?
  • What is Akebia Therapeutics quarterly gross profit year-on-year change?
  • What is Akebia Therapeutics TTM gross profit?
  • What is the all time high TTM gross profit for Akebia Therapeutics?
  • What is Akebia Therapeutics TTM gross profit year-on-year change?

What is Akebia Therapeutics annual gross profit?

The current annual gross profit of AKBA is $97.00M

What is the all time high annual gross profit for Akebia Therapeutics?

Akebia Therapeutics all-time high annual gross profit is $206.92M

What is Akebia Therapeutics annual gross profit year-on-year change?

Over the past year, AKBA annual gross profit has changed by -$23.47M (-19.48%)

What is Akebia Therapeutics quarterly gross profit?

The current quarterly gross profit of AKBA is $49.71M

What is the all time high quarterly gross profit for Akebia Therapeutics?

Akebia Therapeutics all-time high quarterly gross profit is $107.77M

What is Akebia Therapeutics quarterly gross profit year-on-year change?

Over the past year, AKBA quarterly gross profit has changed by +$28.71M (+136.70%)

What is Akebia Therapeutics TTM gross profit?

The current TTM gross profit of AKBA is $125.71M

What is the all time high TTM gross profit for Akebia Therapeutics?

Akebia Therapeutics all-time high TTM gross profit is $210.34M

What is Akebia Therapeutics TTM gross profit year-on-year change?

Over the past year, AKBA TTM gross profit has changed by +$4.05M (+3.33%)
On this page